Results 181 to 190 of about 207,794 (393)

Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis

, 2020
Luca Richeldi, Martin Kolb, S. Jouneau, Wim Wuyts, Birgit Schinzel, Susanne Stowasser, Manuel Quaresma, Ganesh Raghu   +7 more
openalex   +1 more source

Vitamin D and idiopathic pulmonary fibrosis: a two-sample mendelian randomization study [PDF]

, 2023
Tong Lin, Fen Zhou, Haiyan Mao, Zhenye Xie, Yuhong Jin   +4 more
openalex   +1 more source

Impact of moderate to severe obstructive sleep apnea on the cognition in idiopathic pulmonary fibrosis

, 2019
Voicu Tudorache, Daniel Trăilă, Monica Marc, Cristian Oancea, Diana Manolescu, Emanuela Tudorache, Bogdan Timar, Alin Albai, Ovidiu Fira‐Mladinescu   +8 more
openalex   +2 more sources

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis.

New England Journal of Medicine, 2015

semanticscholar   +1 more source

Global Disproportionality Analysis of Adverse Event Reports on Interstitial Lung Diseases for Cancer‐Targeted Therapies, 1968–2024

Respirology, EarlyView.
ABSTRACT Background and Objectives The increasing complexity of interstitial lung disease (ILD) related to cancer‐targeted monoclonal antibodies (mAbs) has emerged as a significant clinical concern. Thus, this study aimed to investigate reporting signals of four ILD subtypes detected with cancer‐targeted mAbs.
Jinyoung Jeong, Hyunjee Kim, Sooji Lee, Jiyoung Hwang, Lee Smith, Ho Geol Woo, Jaehyeong Cho, Dong Keon Yon   +7 more
wiley   +1 more source

Pirfenidone treatment of idiopathic pulmonary fibrosis

Therapeutics and Clinical Risk Management, 2011
Ye Gan1,2, Erica L Herzog2, Richard H Gomer31Department of Medicine, Central South University, Changsha, Hunan, China; 2Department of Medicine, Yale University School of Medicine, New Haven, CT, USA; 3Department of Biology, Texas A&M University ...
Ye Gan, Erica L Herzog, Richard H Gomer
doaj  

Evaluation of progressive pulmonary fibrosis in non-idiopathic pulmonary fibrosis-interstitial lung diseases: a cross-sectional study

BMC Pulmonary Medicine
Background Progressive pulmonary fibrosis is the symptomatic, physiological, and radiological progression of interstitial lung diseases. The aim of this study was to examine the relationship between progressive pulmonary fibrosis and demographic ...
Özlem Erçen Diken, Ömür Güngör, Hüseyin Akkaya   +2 more
doaj   +1 more source

Topographic distribution of idiopathic pulmonary fibrosis: a hybrid physics- and agent-based model

, 2018
Tyler J. Wellman, Jarred R. Mondoñedo, Gerald S. Davis, Jason H. T. Bates, Bélâ Suki   +4 more
openalex   +2 more sources

[Research Progress on Pathogenic Mechanism and Potential Therapeutic Drugs of 
Idiopathic Pulmonary Fibrosis Complicated with Non-small Cell Lung Cancer].

, 2022
Ting Xiao, Jiali Bao, Xiangning Liu, Hui Huang, Honggang Zhou   +4 more
openalex   +2 more sources

Rapid Serological Detection of Anti‐GM‐CSF Autoantibodies in Autoimmune Pulmonary Alveolar Proteinosis Using a Novel Immunochromatographic Test

Respirology, EarlyView.
We developed a novel ICT with high clinical performance that can distinguish APAP patients from those with other pulmonary diseases. The rapid and simple detection of GMAbs in serum provided a new practical method for the diagnosis of APAP. ABSTRACT Background and Objectives Anti‐GM‐CSF autoantibodies (GMAbs) are essential biomarkers for diagnosing ...
Chika Narita, Kenjiro Shima, Jun‐ichiro Sekiguchi, Yasuyuki Ozeki, Makoto Akiwa, Shohei Koike, Sachiko Yuki, Keiichi Akasaka, Toshiaki Kikuchi, Nobutaka Kitamura, Koh Nakata   +10 more
wiley   +1 more source